MedPath

Hypnosis und Progressive Musclerelaxation for stressreduction for mild depression– a prospective, randomized, controlled, exploratory telemedicine pilot study

Not Applicable
Recruiting
Conditions
F32.0
Mild depressive episode
Registration Number
DRKS00032115
Lead Sponsor
Charité - Universitätsmedizin Berlin Institut für Sozialmedizin, Epidemiologie und Gesundheitsokönomie
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
60
Inclusion Criteria

Women, men, and individuals of diverse genders between the ages of 18 and 70.
-Subjective stress level in the past week on the Visual Analog Scale (VAS) 40 mm (VAS 0 - 100 mm, 0 = no stress and 100 = maximum imaginable stress).
-Diagnosis of mild depression according to ICD-10 (F32.0, F33.0) by a specialist in psychiatry and psychotherapy or a licensed psychological psychotherapist.
-Duration of depressive symptoms for at least 2 weeks.
-Capacity to provide informed consent and signed informed consent form.
-Technical equipment to participate in online courses and complete online questionnaires.

Exclusion Criteria

-Known history of severe trauma resulting in post-traumatic stress disorder.
-Diagnosed personality disorder.
-Current or past psychotic disorder
-Acute self-harm or suicidality
-Known severe obsessive-compulsive disorder.
-Alcohol and drug dependency.
-Presence of moderate or severe acute or chronic physical illness. -Participation in another study on depression within the last 2 months prior to study enrollment.
-Lack of understanding of the German language.
-Ongoing disability retirement process.
-Use of hypnosis, self-hypnosis, autogenic training, or progressive muscle relaxation (PMR) currently or within the last 2 months.
-Diagnosis of moderate and severe depressive episode according to ICD-10 (F32.1, F32.2, F33.1, F33.2) by a specialist in psychiatry and psychotherapy or a licensed psychological psychotherapist.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath